Insider · CIK 0002085782
Megan Reimers Bent
Files at OFRM (Once Upon a Farm, PBC). First filing -, latest -.
In brief
Megan Reimers Bent files SEC Form 4 as director at OFRM (Once Upon a Farm, PBC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Megan Reimers Bent has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | OFRM Once Upon a Farm, PBC | AGrant or award Common Stock | +46,039 | - | - | 46,039 | Feb 9, 2026 |
| Feb 9, 2026 | OFRM Once Upon a Farm, PBC | AGrant or award Common Stock | +6,112 | $0.00 | $0 | 52,151 | Feb 9, 2026 |
| Feb 9, 2026 | OFRM Once Upon a Farm, PBC | DDisposition to issuer Series C-1 Preferred Stockderivative | -16,493 | $0.00 | $0 | 0 | Feb 9, 2026 |
| Feb 9, 2026 | OFRM Once Upon a Farm, PBC | DDisposition to issuer Series C-2 Preferred Stockderivative | -29,546 | $0.00 | $0 | 0 | Feb 9, 2026 |
Questions about Megan Reimers Bent
Answered from the filings on this page, as of the latest one.
Is Megan Reimers Bent buying or selling?
Megan Reimers Bent has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Megan Reimers Bent's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Megan Reimers Bent has 0.
Where does Megan Reimers Bent file Form 4?
Megan Reimers Bent has filed Form 4 at OFRM (Once Upon a Farm, PBC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.